Litramine™ is
clinically proven

3. Litramine™ subjects were able to maintain their body weight after initial weight loss

Double-blind, randomized, placebo-controlled study published in JOURNAL OF OBESITY, 2015.
Click here to read the full study.

After 24 weeks, subjects on LitramineTM lost a mean of 0.62kg,
while the placebo group gained a mean of 1.62kg.

Significantly more subjects in the Litramine™ group successfully maintained the
weight loss effect (≤1% weight increase from baseline) after 24 weeks.


Section Reference:
Barbara Grube, Pee-Win Chong, Felix Alt, and Ralf Uebelhack, “Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study,” Journal of Obesity, vol. 2015, Article ID 953138, 6 pages, 2015. doi:10.1155/2015/953138

Previous | Next

Copyright © 2015 by InQpharm Group. All rights reserved. Last updated: Nov 2015 | ID: ML/TM/EN/15/001
Litramine and InQpharm are trademarks of the InQpharm group of companies.